Colon and Rectal Cancer Studies in DCEG
DCEG researchers conduct studies on cancers of the colon and rectum, also known as colorectal cancer. Most colon cancers are adenocarcinomas. Selected studies include:
Studies of Colorectal Cancer
-
Bone Density and Cancer Risk Follow-Up Study of Women in the Fracture Intervention Trial (BFIT)
A retrospective cohort study that uses data from the FIT clinical trial to evaluate how bone mineral density of the hip is related to subsequent cancer risk
-
The CONCeRN Study
Colorectal Neoplasia Screening With Colonoscopy in Asymptomatic Women
-
Human Microbiome and Cancer
Research to characterize the relationships of certain cancers to the full spectrum of microbial flora
-
Polyp Prevention Trial
The primary objective of the Polyp Prevention Trial (PPT) is to determine whether a low fat, high fiber, high vegetable and fruit eating plan will decrease the recurrence of adenomatous polyps of the large bowel.
-
Prostate, Lung, Colon, and Ovary Prospective Study
A large cohort study of etiologic determinants of cancer carried out within an NCI trial for the evaluation of screening procedures for the early detection of prostate, lung, colon, and ovarian cancer (the PLCO Trial) at 10 U.S. screening centers
-
Vitamin D and Cancer Risk and Survival
DCEG scientists investigate the association between Vitamin D and cancer risk.
Risk Prediction Models for Colorectal Cancer
-
Colorectal Cancer Risk Assessment ToolExplanation of absolute risk modeling and how it was used to develop the NCI Risk Assessment tools (breast, colorectal and melanoma)
-
Calculator of Colorectal Cancer Survival ProbabilityA tool to estimate the five-year survival for a patient with colorectal cancer.